dc.contributor.author
Dobbertin‐Welsch, Josefine
dc.contributor.author
Staudacher, Olga
dc.contributor.author
Yürek, Songül
dc.contributor.author
Trendelenburg, Valérie
dc.contributor.author
Tschirner, Sebastian
dc.contributor.author
Ziegert, Mandy
dc.contributor.author
Ahrens, Frank
dc.contributor.author
Millner‐Uhlemann, Martina
dc.contributor.author
Büsing, Susanne
dc.contributor.author
Striegel, Anne
dc.contributor.author
Ott, Hagen
dc.contributor.author
Arens, Alisa
dc.contributor.author
Gappa, Monica
dc.contributor.author
Lange, Lars
dc.contributor.author
Gernert, Sunhild
dc.contributor.author
Niggemann, Bodo
dc.contributor.author
Beyer, Kirsten
dc.date.accessioned
2025-04-01T15:58:30Z
dc.date.available
2025-04-01T15:58:30Z
dc.identifier.uri
https://refubium.fu-berlin.de/handle/fub188/47112
dc.identifier.uri
http://dx.doi.org/10.17169/refubium-46829
dc.description.abstract
Background
Peanut and tree nut allergies are common in childhood and often severe in nature. The clinical picture shows a wide variety of symptoms.
Objective
To analyze the distribution of clinical symptoms and severity during oral food challenges (OFC) in children.
Methods
Analysis of 1.013 prospectively recorded, positive OFCs with peanut (n = 607), hazelnut (n = 266), walnut (n = 97), and cashew (n = 43). Symptoms were categorized as immediate-type skin, gastrointestinal, upper and lower respiratory, cardiovascular symptoms, and eczema exacerbation. Symptom severity and treatment were recorded.
Results
Skin symptoms presented in 78%, followed by gastrointestinal (47%), upper (42%), and lower respiratory symptoms (32%). Cardiovascular symptoms presented in 6%. In three-quarter of the reactions, more than one organ was involved. Importantly, severe reactions occurred at every dose level. Peanut- and cashew-allergic patients had a higher relative risk of gastrointestinal symptoms compared with hazelnut- and walnut-allergic patients. Patients without vomiting had a 1.7 times higher risk developing immediate-type skin and/or lower respiratory symptoms. Three-quarter of the patients ever had eczema but worsening presented in only 10.5% of the OFCs. In patients with multiple food allergies, organs involved, eliciting dose and severity differed between allergens.
Conclusion
Although comparisons between allergen groups with different clinical history, severity, comorbidities and laboratory data are difficult and might contain bias, our data confirm the high allergenic potential of peanut and tree nuts. The rare occurrence of eczema worsening emphasizes that avoidance diets of peanuts and tree nuts to cure eczema seem to be unnecessary and may hamper tolerance maintenance.
en
dc.rights.uri
https://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subject
food allergy
en
dc.subject
organ-specific symptom
en
dc.subject.ddc
600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit::610 Medizin und Gesundheit
dc.title
Organ‐specific symptom patterns during oral food challenge in children with peanut and tree nut allergy
dc.type
Wissenschaftlicher Artikel
dcterms.bibliographicCitation.articlenumber
e13778
dcterms.bibliographicCitation.doi
10.1111/pai.13778
dcterms.bibliographicCitation.journaltitle
Pediatric Allergy and Immunology
dcterms.bibliographicCitation.number
5
dcterms.bibliographicCitation.originalpublishername
Wiley
dcterms.bibliographicCitation.volume
33
refubium.affiliation
Charité - Universitätsmedizin Berlin
refubium.funding
DEAL Wiley
refubium.resourceType.isindependentpub
no
dcterms.accessRights.openaire
open access
dcterms.bibliographicCitation.pmid
35616889
dcterms.isPartOf.issn
0905-6157
dcterms.isPartOf.eissn
1399-3038